Yes, Lyme disease can cause neurological problems, and it does so in roughly 10% to 15% of people whose infections go untreated. These complications typically appear weeks to months after the initial tick bite and can affect the brain, spinal cord, and peripheral nerves. The range of symptoms is wide, from facial drooping and nerve pain to cognitive difficulties that persist long after the infection itself is treated.
How the Bacteria Reaches the Nervous System
The bacterium behind Lyme disease, Borrelia burgdorferi, has an unusual ability to cross the blood-brain barrier, the tightly sealed layer of cells that normally keeps pathogens out of the central nervous system. Rather than breaking through by force, the spirochete (a corkscrew-shaped bacterium) hijacks the body’s own enzyme systems. It binds to a protein called plasminogen on the surface of the barrier’s cells, then triggers those cells to produce enzymes that briefly loosen the junctions between them. Lab studies found that adding plasminogen to the equation increased the number of spirochetes crossing the barrier by more than tenfold. This is a temporary, highly localized process: the barrier stays structurally intact overall, which is part of why the invasion can be difficult to detect early.
Once inside the central nervous system, the bacteria provoke inflammation in the membranes surrounding the brain and spinal cord (meningitis) and along nerve roots. That inflammation is responsible for most of the neurological symptoms people experience.
Early Neurological Symptoms
The most recognizable neurological sign of Lyme disease is facial palsy, a sudden weakness or drooping on one or both sides of the face. According to CDC reporting data, about 9 out of every 100 reported Lyme patients develop facial palsy. It can look identical to Bell’s palsy, and in areas where Lyme is common, a new case of facial palsy during summer months should raise suspicion of a tick-borne infection.
Other early neurological symptoms include:
- Radiculopathy: sharp, shooting nerve pain that radiates along the trunk or limbs, reported in roughly 4% of cases. This pain often worsens at night and can be severe enough to disrupt sleep.
- Meningitis: fever, stiff neck, and intense headache, seen in about 3% of reported cases.
- Numbness and tingling in the hands or feet.
- Visual disturbances caused by inflammation of the nerves controlling eye movement.
These symptoms generally appear during the “early disseminated” stage, which means the infection has spread beyond the original tick bite site but hasn’t been present for months. The timeline is usually a few weeks to a couple of months after infection.
Late-Stage Cognitive and Psychiatric Effects
When Lyme disease goes untreated for months or longer, the neurological picture shifts. Instead of acute nerve inflammation, people often develop a subtler pattern of cognitive impairment sometimes called Lyme encephalopathy. The hallmark is what patients and clinicians describe as brain fog: difficulty concentrating, slowed processing speed, and trouble retrieving words mid-sentence.
Formal neuropsychological testing in people with long-standing Lyme disease has documented measurable deficits in working memory, verbal learning, alertness, and executive function (the mental skills used for planning, organizing, and switching between tasks). One study found that Lyme patients performed worse on tests of verbal ability, language fluency, and paragraph recall than both healthy controls and people with major depression. Memory and processing difficulties can show up as everyday problems like reversing numbers and letters, making spelling mistakes, or losing the thread of a conversation.
Psychiatric symptoms also surface in some patients. Depression, panic attacks, obsessive-compulsive symptoms, and in rare cases psychotic features have all been documented. Women with neuroborreliosis appear to experience cognitive deficits more frequently than men, though the reasons for this aren’t fully understood.
How Lyme Lesions Differ From Multiple Sclerosis
Because Lyme disease can cause white matter changes visible on brain MRI, it sometimes gets confused with multiple sclerosis. The distinction matters enormously since the treatments are completely different. MS produces well-defined, oval-shaped lesions that tend to cluster around the brain’s ventricles and often appear perpendicular to them, a pattern neurologists find characteristic. Acute MS lesions also light up with contrast dye on imaging.
Lyme disease, by contrast, rarely produces prominent brain lesions at all. When white matter changes do appear, they’re typically small, scattered, and nonspecific, looking more like the tiny spots seen with migraines or normal aging than anything diagnostic. What Lyme more commonly shows on MRI is enhancement of the meninges (the brain’s outer lining) or of inflamed nerve roots. Large, confluent lesions near the ventricles, the kind that define MS, are exceedingly rare in Lyme neuroborreliosis.
Diagnosis
Diagnosing neurological Lyme usually requires a lumbar puncture (spinal tap) in addition to blood testing. Doctors look for two main things in the cerebrospinal fluid: elevated white blood cell counts and evidence that the body is producing Lyme-specific antibodies inside the central nervous system rather than just in the blood. An antibody index of 1.5 or higher indicates local antibody production in the brain and spinal cord, which is a strong sign of active neuroborreliosis.
White blood cell counts in the spinal fluid are typically well above normal. In one study of confirmed cases, median counts ranged from about 170 cells per microliter in patients with nerve root inflammation to over 345 in those with meningitis, compared to the normal ceiling of 4. These elevated counts help distinguish active Lyme infection from other conditions that might produce similar symptoms.
Treatment and Recovery
Neurological Lyme disease is treated with antibiotics, typically for 14 days in early cases and 14 to 21 days in late-stage disease. The two most common options are oral doxycycline and intravenous ceftriaxone (a type given through an vein). A large multicenter trial comparing the two found they were essentially equivalent: at 12 months, 51% of patients on doxycycline and 46% on ceftriaxone reported complete resolution of symptoms. Overall, 57% of patients in both groups had no remaining Lyme-related complaints at one year.
This equivalence is good news for patients, since oral doxycycline is far simpler and cheaper than weeks of intravenous treatment. Intravenous antibiotics are typically reserved for people who can’t take oral medication, for instance because of severe vomiting or difficulty swallowing. In those cases, treatment usually starts intravenously and switches to oral doxycycline once symptoms allow, completing a total course of two to three weeks.
Most patients with brain involvement respond to antibiotics within the first week to month. However, recovery isn’t always complete. In a study of patients with Lyme-related brain inflammation, about two-thirds still had residual symptoms at a follow-up roughly 10 months later, and about a third reported meaningful limitations in daily activities. These lingering symptoms, which can include fatigue, cognitive sluggishness, and nerve pain, don’t appear to respond to additional rounds of antibiotics, suggesting they reflect lasting effects of the inflammatory process rather than ongoing active infection.
The speed of treatment matters. People diagnosed and treated early in the course of neurological involvement tend to recover more fully than those whose infections went unrecognized for months. Facial palsy caused by Lyme, for example, typically resolves well with prompt antibiotic therapy, while the cognitive deficits of late-stage disease are more likely to leave some residual impact.